Evaluation of production lots of a rapid point-of-care lateral flow serological test intended for identification of IgM and IgG against the N-terminal part of the spike protein (S1) of SARS-CoV-2

Tove Hoffman, Linda Kolstad, Bengt Rönnberg, Åke Lundkvist
doi: https://doi.org/10.1101/2020.08.27.20182923

Article usage

Article usage: September 2020 to August 2025

AbstractFullPdf
Sep 20205430158
Oct 2020202081
Nov 20201410105
Dec 20203960107
Jan 20213470145
Feb 202193088
Mar 2021112878
Apr 202190351
May 202172046
Jun 202164221
Jul 202140218
Aug 202140730
Sep 202135018
Oct 202137219
Nov 202141229
Dec 20214215
Jan 20224069
Feb 202217110
Mar 202240112
Apr 20222207
May 202217212
Jun 20222304
Jul 20221003
Aug 20222233
Sep 202237914
Oct 20222717
Nov 20221333
Dec 20221428
Jan 20231723
Feb 20231736
Mar 20231222
Apr 20231927
May 20231129
Jun 20231146
Jul 2023402
Aug 202319138
Sep 20231252
Oct 2023815
Nov 202322162
Dec 20232076
Jan 2024723
Feb 2024932
Mar 2024726
Apr 2024578
May 2024845
Jun 20241025
Jul 2024404
Aug 20241846
Sep 202413312
Oct 2024896
Nov 20241236
Dec 202426022
Jan 202543232
Feb 20256116
Mar 202519148
Apr 20251318
May 2025945
Jun 20251978
Jul 20251799
Aug 2025003
Back to top
Posted September 01, 2020.
Download PDF
Data/Code
Email
Evaluation of production lots of a rapid point-of-care lateral flow serological test intended for identification of IgM and IgG against the N-terminal part of the spike protein (S1) of SARS-CoV-2
Tove Hoffman, Linda Kolstad, Bengt Rönnberg, Åke Lundkvist
medRxiv 2020.08.27.20182923; doi: https://doi.org/10.1101/2020.08.27.20182923
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area